Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Bristol-Myers Squibb (BMS) is a global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines. BMS is committed to patients with serious diseases in therapeutic areas such as oncology, immunology, and cardiovascular diseases, aiming to prolong and improve lives.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Bristol-Myers Squibb is scheduled to report its next quarterly earnings on 10/29/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Bristol-Myers Squibb last reported quarterly earnings on 7/30/2026 (Q2 2026). Earnings per share (EPS) came in at 2.04 USD.
Across its last 5 earnings reports, Bristol-Myers Squibb stock moved by ±4.4% on average the following day. The largest reaction was +7.1% on 10/30/2025; 4 of 5 reactions were positive.
Bristol-Myers Squibb has beaten analyst EPS estimates in 5 of its last 5 evaluated quarters (beat rate: 100%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 5 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.